May, 2018 | The Wall Street Analyzer

Latest News

[ December 16, 2024 ] Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryteTM for the Treatment of Cutaneous T-Cell Lymphoma News Feed
[ December 2, 2024 ] HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment News Feed
[ November 20, 2024 ] Peer to Peer Network (OTC: PTOP) Announces Strategic Partnership With Pantheon Technologies to Integrate AI-Powered ARES System Into MOBICARD(TM) Platform News Feed
[ November 1, 2024 ] PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results News Feed
[ October 22, 2024 ] Sequoia Capital and the evolution of the VC industry | FT Film Consumer
[ October 19, 2024 ] Apollo CEO Marc Rowan on Private Markets, US Election, Fed Interest Rates Consumer
[ October 18, 2024 ] Stan Druckenmiller on Fed Policy, Election, Bonds, Nvidia Market News

Pyxis Tankers (NASDAQ: PXS) Management Interview

May 30, 2018 The Wall Street Analyzer Comments Off

Management Interview […]

iAnthus Capital Holdings (OTCQB: ITHUF) (CSE: IAN) CEO: Hadley Ford

May 30, 2018 The Wall Street Analyzer Comments Off

Interview with Hadley Ford, CEO […]

Victoria Gold Provides Eagle Development Update, Yukon Territory

May 25, 2018 The Wall Street Analyzer Comments Off

TORONTO, May 24, 2018 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-V:VIT) “Victoria” or the “Company” is pleased to provide a construction update for the Eagle Gold Mine Project (the “Project”), Yukon Canada. Full construction commenced […]

Acerus Pharmaceuticals Corporation (TSX: ASP) CEO: Ed Gudaitis

May 23, 2018 The Wall Street Analyzer Comments Off

Founded in 2008, Acerus has quickly grown into a fully integrated company with expertise in all stages of the pharmaceutical product lifecycle, and focus in the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). […]

Aerkomm Inc. (OTCQX: AKOM) CEO Interview

May 23, 2018 The Wall Street Analyzer Comments Off

Interview with Jeffrey Wun, CEO […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]

Identillect Technologies (TSXV: ID) (OTC: IDTLF) CEO: Todd Sexton

May 21, 2018 The Wall Street Analyzer Comments Off

Interview with Todd Sexton, CEO […]

US Cobalt Securityholders Overwhelmingly Approve Acquisition by First Cobalt

May 18, 2018 The Wall Street Analyzer Comments Off

(TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) […]

Erytech (NASDAQ: ERYP) Management Interview

May 17, 2018 The Wall Street Analyzer Comments Off

Management Interview […]

Black Iron Inc (TSX: BKI) (OTC: BKIRF) CEO Interview

May 16, 2018 The Wall Street Analyzer Comments Off

Interview with CEO Matt Simpson […]

Featured Interviews

FingerMotion, Inc (NASDAQ: FNGR)

July 18, 2024 0

ABOUT: FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China.As the user base of its primary business continues to grow, the Company is developing additional value-added technologies to market to its users. The vision of the Company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the Company to onboard larger customer bases. FingerMotion eventually hopes to serve over 1 billion users in the China market and eventually expand the model to other regional markets. For more information on FingerMotion, visit: https://fingermotion.com/ […]